Form 4: Agilent VP Controller Boosts Stake with Performance Shares

Agilent Technologies' VP, Corporate Controller, Rodney Gonsalves, acquired common stock through a performance program and received new restricted stock units.

Summary

• Rodney Gonsalves, VP, Corporate Controller at Agilent Technologies, Inc., reported several transactions on November 18, 2025.
• Gonsalves acquired 2,540 shares of common stock under the Agilent Technologies, Inc. Long-Term Performance Program, subject to a 1-year post-vest holding period.
• He disposed of 883 shares of common stock at a price of $143.84 per share to cover tax liabilities related to the vesting of restricted stock units.
• Gonsalves was granted 2,402 Restricted Stock Units (RSUs) under the Agilent Technologies, Inc. 2018 Stock Plan, which will vest in four equal annual installments starting November 18, 2026.
• Following these transactions, Gonsalves directly beneficially owns 34,983.6872 shares of common stock and indirectly owns 40.192 shares through the Gonsalves Trust.

Sentiment

Score: 6

Explanation: Slightly positive due to the issuance of performance shares and grant of new RSUs, indicating ongoing executive compensation and alignment with company performance, offset by routine tax-related share disposition.

Positives

• Issuance of 2,540 shares of common stock to the reporting person under the Long-Term Performance Program, indicating achievement of performance targets.
• Grant of 2,402 Restricted Stock Units (RSUs) aligns management interests with long-term shareholder value.

Negatives

• Disposition of 883 shares to satisfy tax liability, which reduces direct beneficial ownership.

Future Outlook

The 2,402 Restricted Stock Units granted will vest in four equal annual installments beginning on November 18, 2026, indicating future equity compensation for the reporting person. The 2,540 performance shares are subject to a 1-year post-vest holding period.

Industry Context

This filing reflects routine executive compensation practices within the technology and life sciences tools industry, where equity grants like performance shares and restricted stock units are common mechanisms to incentivize and retain key executives, aligning their interests with long-term company performance.

Comparison to Industry Standards

• The use of performance-based share grants and Restricted Stock Units (RSUs) is a standard practice for executive compensation in the technology and life sciences sectors, similar to companies like Thermo Fisher Scientific (TMO) or Danaher Corporation (DHR), which frequently utilize such equity incentives to align executive interests with shareholder value creation.
• The disposition of shares to cover tax liabilities upon vesting is also a common and expected event for equity compensation, consistent with practices observed across publicly traded companies.

Corporate Governance

Related Party Transactions

• Shares are indirectly held by the Gonsalves Trust, for which Rodney and Rochelle Gonsalves are trustees. This is a personal trust of the reporting person.

Stakeholder Impact

• Shareholders: The issuance of new shares and RSUs could lead to minor dilution but also aligns executive interests with long-term shareholder value.
• Employees: Reflects the company's compensation structure for key executives, potentially setting a precedent or standard for other high-level employees.

Next Steps

• The 2,402 Restricted Stock Units will begin vesting in four equal annual installments starting November 18, 2026.
• The 2,540 shares acquired under the Long-Term Performance Program are subject to a 1-year post-vest holding period.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation transactions, including the vesting of performance shares and the grant of new restricted stock units, along with a standard disposition of shares for tax purposes. These events are expected and do not indicate any material change in the company's fundamental outlook or operational performance. Therefore, a 'hold' recommendation is appropriate as the filing does not provide new information that would warrant a change in investment thesis.

Keywords

Agilent Technologies, A, Rodney Gonsalves, Form 4, Insider Trading, Stock Grant, Restricted Stock Units, Performance Shares, Executive Compensation, Beneficial Ownership